MENU
LPTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Leap Therapeutics (LPTX) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

LPTX is expected to report earnings to fall 72.50% to -8 cents per share on August 11

Leap Therapeutics LPTX Stock Earnings Reports
Q2'23
Est.
$-0.09
Q1'23
Missed
by $0.23
Q4'22
Est.
$-0.11
Q3'22
Missed
by $0.01
Q2'22
Missed
by $0.05
The last earnings report on May 15 showed earnings per share of -31 cents, missing the estimate of -8 cents. With 187.50K shares outstanding, the current market capitalization sits at 119.17M.
View a ticker or compare two or three
LPTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in clinical stage immuno-oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
47 Thorndike Street
Phone
+1 617 714-0360
Employees
54
Web
https://www.leaptx.com